Phorbol 12-myristate 13-acetate (PMA) suppresses high Ca2+-enhanced adipogenesis in bone marrow stromal cells

The Journal of Physiological Sciences - Tập 69 - Trang 741-748 - 2019
Ryota Hashimoto1, Yuki Miyamoto2, Seigo Itoh2, Hiroyuki Daida2, Takao Okada1, Youichi Katoh2,3
1Department of Physiology, Juntendo University Faculty of Medicine, Tokyo, Japan
2Department of Cardiology, Juntendo University Graduate School of Medicine, Tokyo, Japan
3Juntendo University Faculty of International Liberal Arts, Tokyo, Japan

Tóm tắt

We have previously reported that increased extracellular and intracellular Ca2+ lead to adipocyte accumulation in bone marrow stromal cells (BMSCs). However, strategies to suppress high Ca2+-enhanced adipocyte accumulation have not been reported. We examined the effects of the diacylglycerol analog phorbol 12-myristate 13-acetate (PMA) on proliferation and adipogenesis of mouse primary BMSCs. We used 9 mM CaCl2 and 100 nM ionomycin to increase extracellular Ca2+ and intracellular Ca2+, respectively. PMA suppressed the expression of both C/EBPα and PPARγ under normal adipogenesis, adipogenesis + CaCl2, and adipogenesis + ionomycin conditions. PMA enhanced proliferation under normal adipogenesis conditions but suppressed proliferation under adipogenesis + CaCl2 and adipogenesis + ionomycin conditions. PMA did not affect the accumulation of adipocytes under normal adipogenesis conditions but suppressed adipocyte accumulation under adipogenesis + CaCl2 and adipogenesis + ionomycin conditions. These results suggest that the PMA-dependent pathway is an important signaling pathway to suppress high Ca2+-enhanced adipocyte accumulation.

Tài liệu tham khảo

Ambrosi TH, Scialdone A, Graja A, Gohlke S, Jank AM, Bocian C, Woelk L, Fan H, Logan DW, Schurmann A, Saraiva LR, Schulz TJ (2017) Adipocyte accumulation in the bone marrow during obesity and aging impairs stem cell-based hematopoietic and bone regeneration. Cell Stem Cell 20:771–784 Compston J (2018) Glucocorticoid-induced osteoporosis: an update. Endocrine 61:7–16 Hachemi Y, Rapp AE, Picke AK, Weidinger G, Ignatius A, Tuckermann J (2018) Molecular mechanisms of glucocorticoids on skeleton and bone regeneration after fracture. J Mol Endocrinol 61:R75–R90 Beekman KM, Veldhuis-Vlug AG, den Heijer M, Maas M, Oleksik AM, Tanck MW, Ott SM, van't Hof RJ, Lips P, Bisschop PH, Bravenboer N (2017) The effect of raloxifene on bone marrow adipose tissue and bone turnover in postmenopausal women with osteoporosis. Bone 118:62–68 Syed FA, Oursler MJ, Hefferanm TE, Peterson JM, Riggs BL, Khosla S (2008) Effects of estrogen therapy on bone marrow adipocytes in postmenopausal osteoporotic women. Osteoporos Int 19:1323–1330 Naveiras O, Nardi V, Wenzel PL, Hauschka PV, Fahey F, Daley GQ (2009) Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature 460:259–263 Payne MW, Uhthoff HK, Trudel G (2007) Anemia of immobility: caused by adipocyte accumulation in bone marrow. Med Hypotheses 69:778–786 Elbaz A, Wu X, Rivas D, Gimble JM, Duque G (2010) Inhibition of fatty acid biosynthesis prevents adipocyte lipotoxicity on human osteoblasts in vitro. J Cell Mol Med 14:982–991 Maurin AC, Chavassieux PM, Frappart L, Delmas PD, Serre CM, Meunier PJ (2000) Influence of mature adipocytes on osteoblast proliferation in human primary cocultures. Bone 26:485–489 Maurin AC, Chavassieux PM, Vericel E, Meunier PJ (2002) Role of polyunsaturated fatty acids in the inhibitory effect of human adipocytes on osteoblastic proliferation. Bone 31:260–266 Lecka-Czernik B, Moerman EJ, Grant DF, Lehmann JM, Manolagas SC, Jilka RL (2002) Divergent effects of selective peroxisome proliferator-activated receptor-gamma 2 ligands on adipocyte versus osteoblast differentiation. Endocrinology 143:2376–2384 Silver IA, Murrills RJ, Etherington DJ (1988) Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. Exp Cell Res 175:266–276 Hashimoto R, Katoh Y, Miyamoto Y, Itoh S, Daida H, Nakazato Y, Okada T (2015) Increased extracellular and intracellular Ca(2)(+) lead to adipocyte accumulation in bone marrow stromal cells by different mechanisms. Biochem Biophys Res Commun 457:647–652 Hashimoto R, Katoh Y, Nakamura K, Itoh S, Iesaki T, Daida H, Nakazato Y, Okada T (2012) Enhanced accumulation of adipocytes in bone marrow stromal cells in the presence of increased extracellular and intracellular [Ca(2)(+). Biochem Biophys Res Commun 423:672–678 Song JK, Lee CH, Hwang SM, Joo BS, Lee SY, Jung JS (2014) Effect of phorbol 12-myristate 13-acetate on the differentiation of adipose-derived stromal cells from different subcutaneous adipose tissue depots. Korean J Physiolog Pharmacol 18:289–296 Akune T, Ohba S, Kamekura S, Yamaguchi M, Chung UI, Kubota N, Terauchi Y, Harada Y, Azuma Y, Nakamura K, Kadowaki T, Kawaguchi H (2004) PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest 113:846–855 Beresford JN, Bennett JH, Devlin C, Leboy PS, Owen ME (1992) Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J Cell Sci 102(Pt 2):341–351 Pei L, Tontonoz P (2004) Fat’s loss is bone’s gain. J Clin Invest. 113:805–806 Hashimoto R, Kakigi R, Nakamura K, Itoh S, Daida H, Okada T, Katoh Y (2017) LPS enhances expression of CD204 through the MAPK/ERK pathway in murine bone marrow macrophages. Atherosclerosis 266:167–175 Hashimoto R, Katoh Y, Miyamoto Y, Nakamura K, Itoh S, Daida H, Nakazato Y, Okada T (2017) High extracellular Ca(2 +) enhances the adipocyte accumulation of bone marrow stromal cells through a decrease in cAMP. Cell Calcium 67:74–80 Ishiyama M, Miyazono Y, Sasamoto K, Ohkura Y, Ueno K (1997) A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability. Talanta 44:1299–1305 Carroll MP, May WS (1994) Protein kinase C-mediated serine phosphorylation directly activates Raf-1 in murine hematopoietic cells. J Biol Chem 269:1249–1256 Marquardt B, Frith D, Stabel S (1994) Signalling from TPA to MAP kinase requires protein kinase C, raf and MEK: reconstitution of the signalling pathway in vitro. Oncogene 9:3213–3218 Camp HS, Tafuri SR (1997) Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase. J Biol Chem 272:10811–10816 Hu E, Kim JB, Sarraf P, Spiegelman BM (1996) Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma. Science 274:2100–2103 Marshall CJ (1995) Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179–185 Osaki LH, Gama P (2013) MAPKs and signal transduction in the control of gastrointestinal epithelial cell proliferation and differentiation. Int J Mol Sci 14:10143–10161 Severin S, Ghevaert C, Mazharian A (2010) The mitogen-activated protein kinase signaling pathways: role in megakaryocyte differentiation. J Thromb Haemost 8:17–26 Kim KA, Kim JH, Wang Y, Sul HS (2007) Pref-1 (preadipocyte factor 1) activates the MEK/extracellular signal-regulated kinase pathway to inhibit adipocyte differentiation. Mol Cell Biol 27:2294–2308 Deliot N, Constantin B (2015) Plasma membrane calcium channels in cancer: alterations and consequences for cell proliferation and migration. Biochim Biophys Acta 1848:2512–2522 Maklad A, Sharma A, Azimi I (2019) Calcium signaling in brain cancers: roles and therapeutic targeting. Cancers 11:145–160 Munaron L, Antoniotti S, Lovisolo D (2004) Intracellular calcium signals and control of cell proliferation: how many mechanisms? J Cell Mol Med 8:161–168 Parkash J, Asotra K (2010) Calcium wave signaling in cancer cells. Life Sci 87:587–595